Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The specific treatment regimen for tazemetostat should be determined by a qualif···【more】
Release date：2026-03-26Recommended：271
Pirtobrutinib is a BTK inhibitor developed by Eli Lilly and Company in the Unite···【more】
Release date：2026-03-25Recommended：349
During treatment with pirtobrutinib, some side effects may occur, and these effe···【more】
Release date：2026-03-25Recommended：346
For Patients with Severe Renal Impairment(1). If the current dose is 200 mg once···【more】
Release date：2026-03-25Recommended：377
Pirtobrutinib is a non-covalent (reversible) Bruton's tyrosine kinase (BTK) ···【more】
Release date：2026-03-25Recommended：386
Enasidenib helps restore the normal differentiation of leukemia cells by inhibit···【more】
Release date：2026-03-24Recommended：288
The dosage and administration of enasidenib must strictly follow medical advice ···【more】
Release date：2026-03-24Recommended：264
The use of tepotinib must strictly adhere to the principle of individualized tre···【more】
Release date：2026-03-24Recommended：287
Side Effects of TepotinibPatients should schedule regular follow-ups during trea···【more】
Release date：2026-03-24Recommended：302
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA···【more】
Release date：2026-03-23Recommended：338
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration ···【more】
Release date：2026-03-23Recommended：363
KRAS mutations have long been considered a major challenge in cancer research, r···【more】
Release date：2026-03-23Recommended：287
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
